This company has been marked as potentially delisted and may not be actively trading. XORTX Therapeutics (XRTX) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsEarningsHeadlinesShort InterestTrendsBuy This Stock XRTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period XORTX Therapeutics to Host Investor Webinar on Strategic DevelopmentsSeptember 4 at 8:11 AM | tipranks.comJoin XORTX for an Exclusive Live Investor Webinar and Q&A Session on September 10September 4 at 7:11 AM | financialpost.comFXortx Therapeutics initiates IND preparation for XORLO in gout programSeptember 3, 2025 | msn.comXORTX Advances Gout Treatment Program with IND PreparationSeptember 3, 2025 | tipranks.comXORTX Initiates IND Preparation for XORLO™ in Gout ProgramSeptember 3, 2025 | financialpost.comFXORTX Initiates IND Preparation for XORLO™ in Gout ProgramSeptember 3, 2025 | globenewswire.comXORTX Therapeutics Reports Financial Results for Mid-2025August 16, 2025 | msn.comXORTX Therapeutics Completes $114,500 Private Placement to Fund Gout ProgramsAugust 9, 2025 | msn.comXORTX Completes USD $114,500 Private PlacementAugust 8, 2025 | financialpost.comFXORTX Completes USD $114,500 Private PlacementAugust 8, 2025 | globenewswire.comXORTX Therapeutics Announces $114,500 Private Placement to Support Gout ProgramsAugust 3, 2025 | theglobeandmail.comXORTX Therapeutics Completes US$925,000 Private Placement to Fund Gout ProgramsJuly 22, 2025 | tipranks.comXORTX Completes Non-Brokered Private Placement of UnitsJuly 22, 2025 | globenewswire.comXRTX XORTX Therapeutics Inc. - Seeking AlphaJune 29, 2025 | seekingalpha.comXORTX Announces USD $925,000 Private PlacementJune 26, 2025 | globenewswire.comXORTX Therapeutics looks to raise $3M through private placementMay 19, 2025 | msn.comXORTX Announces USD $3 Million OfferingMay 19, 2025 | globenewswire.comXORTX Therapeutics receives Nasdaq notice for non-complianceApril 18, 2025 | msn.comXORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price DeficiencyApril 17, 2025 | globenewswire.comXORTX Therapeutics Inc (XRTX) Gets a Buy from Alliance Global PartnersFebruary 27, 2025 | markets.businessinsider.comXORTX Announces Change of AuditorJanuary 17, 2025 | globenewswire.comXORTX Announces Presentation at the Rare and Genetic Disease SummitDecember 12, 2024 | globenewswire.comXORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private PlacementOctober 18, 2024 | globenewswire.comXORTX Therapeutics stock falls after pricing $1.5M capital raiseOctober 17, 2024 | msn.comXORTX Initiates Precision Medicine ProgramOctober 9, 2024 | globenewswire.comXRTX:CA XORTX Therapeutics Inc.October 1, 2024 | seekingalpha.comXORTX Announces Results of Annual and Special Meeting of ShareholdersSeptember 13, 2024 | globenewswire.comXORTX Announces Re-filing of YE 2023 and Q2 2024 MD&ASeptember 12, 2024 | globenewswire.comXORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of ShareholdersSeptember 6, 2024 | globenewswire.comIndependent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of ShareholdersSeptember 3, 2024 | globenewswire.comXORTX Therapeutics (NASDAQ:XRTX) Stock, Short Interest ReportAugust 30, 2024 | benzinga.comXORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and Special Meeting of ShareholdersAugust 23, 2024 | globenewswire.comXORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024August 20, 2024 | globenewswire.comClosing Bell: Xortx Therapeutics Inc down on Friday (XRTX)August 4, 2024 | theglobeandmail.comXRTX Stock Earnings: XORTX Therapeutics Reported Results for Q1 2024May 20, 2024 | msn.comXORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPOMay 17, 2024 | globenewswire.comXORTX Reprices Warrants Issued in Connection with Previous Private PlacementsApril 30, 2024 | globenewswire.comXORTX Therapeutics Inc. (XRTX.V)April 26, 2024 | ca.finance.yahoo.comXORTX Announces Publication of Key Research in ADPKDApril 22, 2024 | globenewswire.comXORTX Welcomes New Member to the Board of DirectorsApril 8, 2024 | globenewswire.comXORTX Therapeutics Inc XRTXApril 5, 2024 | morningstar.comMXORTX Therapeutics Inc. Common Stock (XRTX)March 31, 2024 | nasdaq.comXORTX Announces New Clinical Advisory Board MemberMarch 27, 2024 | globenewswire.comXORTX: A Year of Milestones and Strategic Advancements as it Readies for a Registration Clinical TrialMarch 19, 2024 | finance.yahoo.comXORTX Highlights Achievements of 2023 and Preparation for Registration Clinical TrialMarch 19, 2024 | globenewswire.comXORTX Reprices Warrants Issued in Connection with Previous Private PlacementsMarch 11, 2024 | finance.yahoo.comXORTX Therapeutics (Nasdaq:XRTX) HeadlineTrading was temporarily halted for "XRTX" at 09:03 AM with a stated reason of "LULD pause."...March 7, 2024 | marketbeat.comXORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsMarch 4, 2024 | globenewswire.comXORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsFebruary 15, 2024 | finance.yahoo.comXORTX Files an Amended and Restated Prospectus Supplement for the Offering of UnitsFebruary 2, 2024 | finance.yahoo.com Get XORTX Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for XRTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XRTX Media Mentions By Week XRTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XRTX News Sentiment▼0.000.72▲Average Medical News Sentiment XRTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XRTX Articles This Week▼60▲XRTX Articles Average Week Get the Latest News and Ratings for XRTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for XORTX Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies SCNX News NERV News LPCN News BLRX News PRPH News TXMD News APM News MRKR News BIVI News LYRA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XRTX) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTurn $1K into $50K with This DeFi GemBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XORTX Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XORTX Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
